4.6 Article

Neuroprotective effects of Sonic hedgehog agonist SAG in a rat model of neonatal stroke

Journal

PEDIATRIC RESEARCH
Volume 90, Issue 6, Pages 1161-1170

Publisher

SPRINGERNATURE
DOI: 10.1038/s41390-021-01408-7

Keywords

-

Categories

Funding

  1. American Heart Association
  2. Children's Heart Foundation
  3. Cerebral Palsy Alliance Research Foundation
  4. Harrington Discovery Institute
  5. UK MS Society
  6. Adelson Medical Research Foundation
  7. National Institutes of Health, NINDS [P01-NS083513, K99-NS117804, R01-NS107039, U01-NS092764]
  8. Wellcome Trust
  9. NIHR Cambridge Biomedical Research Centre

Ask authors/readers for more resources

The Sonic hedgehog agonist SAG demonstrated neuroprotective effects in neonatal stroke and adult white matter injury, reducing brain damage and improving long-term behavioral outcomes. This study expands the potential use of Sonic hedgehog in treating developing brain injury, adding to previous research in models of Down syndrome and cerebellar injury.
Background Neonatal stroke affects 1 in 2800 live births and is a major cause of neurological injury. The Sonic hedgehog (Shh) signaling pathway is critical for central nervous system (CNS) development and has neuroprotective and reparative effects in different CNS injury models. Previous studies have demonstrated beneficial effects of small molecule Shh-Smoothened agonist (SAG) against neonatal cerebellar injury and it improves Down syndrome-related brain structural deficits in mice. Here we investigated SAG neuroprotection in rat models of neonatal ischemia-reperfusion (stroke) and adult focal white matter injury. Methods We used transient middle cerebral artery occlusion at P10 and ethidium bromide (EB) injection in adult rats to induce damage. Following surgery and SAG or vehicle treatment, we analyzed tissue loss, cell proliferation and fate, and behavioral outcome. Results We report that a single dose of SAG administered following neonatal stroke preserved brain volume, reduced gliosis, enhanced oligodendrocyte progenitor cell (OPC) and EC proliferation, and resulted in long-term cognitive improvement. Single-dose SAG also promoted proliferation of OPCs following focal demyelination in the adult rat. Conclusions These findings indicate benefit of one-time SAG treatment post insult in reducing brain injury and improving behavioral outcome after experimental neonatal stroke. Impact A one-time dose of small molecule Sonic hedgehog agonist protected against neonatal stroke and improved long-term behavioral outcomes in a rat model. This study extends the use of Sonic hedgehog in treating developing brain injury, previously shown in animal models of Down syndrome and cerebellar injury. Sonic hedgehog agonist is one of the most promising therapies in treating neonatal stroke thanks to its safety profile and low dosage.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available